Shares of Rigel Pharmaceuticals jumped more than 15% as the biotech company announced an exclusive $960 million collaboration with Eli Lilly to develop …
Rigel Pharmaceuticals’ (RIGL) long-suffering bulls finally have reason to celebrate: The stock is up nearly 11% in pre-market trading Wednesday after the company …
H.C.
It’s a big day for Rigel Pharmaceuticals (NASDAQ:RIGL). The drug maker has just announced that the FDA has approved its chronic immune thrombocytopenia (ITP) drug …
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors have a smile on their faces Monday morning, after the drug maker announced that the FDA is currently …
